Next Article in Journal
Smartphone-Based Quantitative Measurement of Capillary Refill Time
Next Article in Special Issue
Cyclotron Production and Purification of 83Sr as a 90Sr Substitute for Positron Emission Tomography (PET)
Previous Article in Journal
Enhanced Optical Triangulation Method for Piezoelectric Stack
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Production and Purification of 165Er from Pressed Ho2O3:Al Targets on a 16.5 MeV Cyclotron

The Hevesy Laboratory, Department of Health Technology, Technical University of Denmark, Frederiksborgvej 399, Building 202, 4000 Roskilde, Denmark
*
Author to whom correspondence should be addressed.
Instruments 2026, 10(1), 14; https://doi.org/10.3390/instruments10010014
Submission received: 20 January 2026 / Revised: 16 February 2026 / Accepted: 24 February 2026 / Published: 27 February 2026

Abstract

Erbium-165 (165Er) is an Auger electron emitter with 7.2 electrons per decay and very few other emissions, making it an interesting candidate for Auger electron therapy. We present here a procedure for producing 165Er by the natHo(p,n)165Er nuclear reaction on a 16.5 MeV medical cyclotron. The target was prepared by pressing a Ho2O3:Al 1:1 (w/w) powder mixture on a Ag disc with a cylindrical depression in the center. With a 0.1 mm Nb foil in front, degrading the energy to 15 MeV, and water cooling at the back of the Ag disc, the target could withstand irradiation at currents up to 45 µA without showing any signs of damage. The beam tolerance of the target was also estimated by calculating the temperature and heat dissipation in the target via the numerical solution of the heat transport equations. For a 180 mg target, the production yield was 12.3 ± 1.9 MBq/µAh. The separation of two neighboring lanthanides is challenging, which led us to study the distribution coefficients for Er and Ho on commercially available LN2 resin for both HNO3 and HCl eluents. Based on these values, we propose a purification procedure involving two successive LN2 columns for separating the 165Er from Ho and Al, followed by a small TK221 column to concentrate the final eluate. No radionuclidic impurities were detected, and the chemical impurities found in the final formulation were traces of Ho, Er, Ca, Pb, and Fe. For three different chelators (DOTA, DTPA, and CHX-A″-DTPA), the effective molar activity of the final formulation was measured. The stability of the three complexes formed was also assessed upon incubation in mouse serum for 28 h.

1. Introduction

Auger electron (AE) emitters are increasingly attracting attention due to their potential for targeted radionuclide therapy. The high energy deposition within a very short range associated with an AE cascade holds good promise for efficiently killing targeted cancer cells while sparing the surrounding healthy tissues [1]. The therapeutic properties of AEs are believed to be especially suitable for the elimination of single cells and small metastatic tumors. The efficient elimination of such cancer cells could greatly increase the outcome of targeted radiation therapy by potentially lowering the risk of tumor regrowth and relapse of the disease after treatment [2]. This is supported by the fact that Auger and conversion electrons were shown to have a positive effect on the therapeutic efficacy of terbium-161 (161Tb), compared to the more commonly used β- emitter luthetium-177 (177Lu) [3,4]. Both radionuclides have similar half-lives and emit β- radiation of a similar energy range, but 161Tb emits a considerable amount of Auger and conversion electrons compared to 177Lu. 165Er (T½: 10.36 h) decays by electron capture and is an AE emitter with 7.2 electrons per decay [5], with very few other emissions. It does not emit any γ-rays nor conversion electrons upon decay and only low-energy X-rays [6,7]. This is an advantage in terms of a decreased dose to surrounding healthy tissue and less exposure to the personnel handling the radiopharmaceutical. The emission of γ-rays with an energy of 60–300 keV can be advantageous for dosimetry calculations and single-photon emission computed tomography (SPECT) [5], and a recent study has demonstrated that the X-ray emissions of 165Er were sufficient to perform SPECT imaging in small animals, making it a potential theranostic radionuclide for translational AE therapy studies [8]. 165Er has also been considered for bimodal imaging as an analogue to gadolinium [9]. An additional advantage of 165Er is that the chelator, DOTA, can be labeled, which is commonly used for radiopharmaceuticals [8].
165Er can be produced by the (p,n) nuclear reaction from natural Ho, which is monoisotopic. The maximal cross section for the natHo(p,n)165Er reaction is around 160–180 mb in the 10–11 MeV range [10,11,12,13], enabling the 165Er production on a 16.5 MeV medical cyclotron. Another production route that has been reported is via the natEr(p,xn)165Tm reaction. With its 30.06 h half-life, the thulium-165 (165Tm) can act as a 165Er generator afterwards. The advantage of the natEr(p,xn)165Tm production route is the higher cross-section of the reaction with a maximum around 450 mb at 23 MeV [14]. It, however, leads to the production of a mixture of Tm radionuclides. The use of an enriched 166Er target and subsequent 166Er(p,2n)165Tm nuclear reaction can reduce the amount of produced Tm isotopes [15,16]. The use of a deuteron beam to produce 165Er by the 165Ho(d,2n)165Er nuclear reaction has also been reported. The maximal cross section is close to 600 mb, but this route requires cyclotrons with higher energy than for the (p,n) reaction route, which are less available [17].
The most used target material for producing 165Er by the natHo(p,n)165Er reaction is metallic Ho, mostly as foil [9,12,18] but also as pressed powder [12] or pressed and melted chips [19]. However, Er is a common impurity in metallic Ho, which cannot be chemically separated from 165Er, leading to reduced molar activity. A pre-purification of the target material to remove Er and a regeneration of Ho in metallic form are difficult. Ho2O3 is an alternative and has the advantage of being available in high purity (99.999%). It is also possible to purify the target material and recover the Ho2O3 [12]. The properties of Ho2O3 as a cyclotron target material are not as suitable as metallic Ho, due to a lower thermal conductivity and the presence of oxygen that will stop some of the proton beam and decrease the 165Er production yield. To increase the mechanical properties and thermal conductivity of a pressed powder target, we have previously added Al powder to a [135Ba]BaCO3 target for lanthanum-135 (135La) production with success, making it possible to increase the beam current on the target [20]. Al was chosen due to its relatively high thermal conductivity, low stopping power, and the fact that it is a soft metal, making it possible to press the target material in the Ag discs used as target backing. Additionally, Al can be chemically separated from lanthanides, and no long-lived radionuclides are produced by the (p,n) nuclear reaction.
In this work, we describe the cyclotron production of 165Er from pressed targets made of a combination of Ho2O3 and Al powder and study the stability and beam tolerance of the target experimentally and theoretically by partial differential equations. The separation of two neighboring lanthanides comes with some challenges due to their similar chemical behaviors. The distribution of Er and Ho on commercially available LN2 resin was measured, and the 165Er purification was performed on three successive columns that led to a purity suitable for radiolabeling. The apparent molar activity was determined from inductively coupled plasma optical emission spectroscopy (ICP-OES), and the effective molar activities were measured by titration with the DOTA, DTPA, and CHX-A′′-DTPA chelators due to their known ability to form stable complexes with the lanthanides [21,22,23]. The stability of the three 165Er complexes was then assessed after incubation at 37 °C in mouse serum over 28 h.

2. Materials and Methods

The chemicals were purchased from Merck (Darmstadt, Germany) unless otherwise specified and used without further purification. Ho2O3 of high purity (99.999%, trace rare earth analysis ≤15.0 ppm, Sigma-Aldrich (St. Louis, MO, USA)) and HCl and HNO3 of “Suprapur” quality were used for the experiments. The Al powder (99.9%, 60 µm max. particle size) and Nb foil were purchased from Goodfellow (Huntingdon, England). The water was of 18 MΩ MilliQ-grade (Roskilde, Denmark), except for the labeling experiments, in which case ultra-trace water was used. 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid (DOTA), diethylene triaminepentaacetic acid (DTPA), and p-NO2-Bn-CHX-A″-DTPA ([(R)-2-Amino-3-(4-nitrophenyl)propyl]-trans-(S,S)-cyclohexane-1,2-diamine-pentaacetic acid (CHX-A′′-DTPA)) were purchased from Macrocyclics (Plano, TX, USA). Mouse serum was purchased from Biowest (Nuaillé, France). The targets were irradiated on a GE PETtrace cyclotron with a 16.5 MeV proton beam. For the purification, the LN2 (50–100 µm), branched DGA (50–100 µm), and TK221 (50–100 µm) resins were purchased from TRISKEM (Bruz, France). The columns were run using a BT100-2J LongerPump peristaltic pump (supplied by Drifton, Hvidovre, Denmark). Non-radioactive metal impurities in the final sample were quantified by ICP-OES with a Thermo Scientific iCAP 6000 and 7000 Plus Series ICP-OES apparatus (supplied by Thermo Fisher Scientific, Roskilde, Denmark), and Er, Ho, and multielement 1 ICP standard solutions were used for the quantification. Sample activities were measured using a Canberra GC 2020 high-purity germanium (HPGe) detector gamma spectrometer (Olen, Belgium), a Canberra GL 0055P X-ray detector (Olen, Belgium), and a CRC-55tR, CII Capintec, Inc., (Florham Park, NJ, USA) dose calibrator. The HPGe detector for gamma spectrometry was calibrated with certified 133Ba and 152Eu sources and the X-ray detector with certified 241Am and 210Pb sources. Spectra were analyzed using Genie 2000 software. For the effective molar activity measurements, the thin-layer chromatography (TLC) plates (TLC Silica gel 60 F254 plates (aluminum sheets), Supelco, Darmstadt, Germany) were read using a Perkin Elmer Cyclone® Plus Storage Phosphor System apparatus (Perkin Elmer, Singapore).

2.1. Target Preparation and Irradiation

For the production of 165Er, different mixtures of Ho2O3:Al (without Al, 7:3, 1:1, and 1:2 w/w, 80–270 mg total weight) were pressed in a Ag disc (29 mm diameter, 5 mm thickness) with a cylindrical well in the center (9 mm diameter, 3 mm depth). A hydraulic press (1 ton) was used with a matching stainless steel pressing tool. The Ag disc was placed in a target holder with water cooling on the back of the disc. A 0.1 mm-thick Nb foil (45–50 × 45–50 mm dimensions) was placed in front of the target, degrading the incoming proton beam to 15.0 MeV. For target testing and work on the purification procedure, low activity batches were produced by irradiating the target for 10–15 min at 10–50 µA. For high activity batches, targets were irradiated up to 3 h at 25 µA. To be able to track both Ho and Er during optimization of the purification procedure, we also used radioactive Ho made on-site by neutron activation. For this, 100 mg Ho2O3 in an Eppendorf tube was immersed in a bucket filled with water (4–5 L) placed just behind a standard 18F target. The water bucket acted as a moderator to thermalize the neutrons generated by the 18O(p,n)18F reaction. A routine 18F production led to the generation of small amounts of 166Ho (T½: 26.8 h). The bucket was retrieved after the cyclotron run, and the Ho sample contained 17–42 kBq of 166Ho, which was dissolved in 5 mL 4 M HCl.

2.2. Simulation of the Thermal Performance of the Target

To estimate the maximum beam current that the Ho2O3:Al cyclotron target can tolerate, the heat dissipation and thermal performance of the target were simulated in MATLAB R2025b using similar calculations, as previously described [24,25]. The temperature in the target was calculated from partial differential equations defined for the geometry of the target, including the Nb degrader foil, the Ho2O3:Al target mixture, the air between the foil and the target material, the Ag backing, and the water cooling on the back of the Ag disc. A steady-state model for the conductive heat transfer was used, where the temperature does not change with time. The target was defined as a heat source Q and calculated from Equation (1), where k is the thermal conductivity and T the temperature [24].
( k T ) = Q
The thermal conductivity of the target material, Ag backing, Nb foil, and the air between the target and the foil were used in the model. The thermal conductivity of the Ho2O3:Al 1:1 (w/w) mixture was not known and was initially set to 30 W/m·K, since the thermal conductivity of Al is 273 W/m·K [26] and the thermal conductivity of Ho2O3 is expected to be below the value for metallic Ho (16 W/m·K).
The boundary conditions were set to 20 °C. The water-cooling flow rate was set to 1 L/min, and the tubing diameter was 7 mm. The convective heat transfer coefficient for the water cooling was calculated from Equation (2), where D is the hydraulic diameter, ρ the density, ν the velocity of flow, μ the dynamic viscosity, and Cp the specific heat capacity of water [24].
h = 0.023 k D ρ ν D μ 0.8 μ C p k 0.4
The incoming power from the proton beam was calculated from the beam energy and current. The beam tolerance of the target was assessed by calculating the temperature of the Nb degrader and of the Ho2O3:Al 1:1 (w/w) target material at different beam currents. The limit of the target was assumed to be at the beam current where the temperature of the Nb foil or the target material exceeded the melting point of Nb or Al, respectively. The experimental data were subsequently used to calibrate the code and calculate the thermal conductivity of the Ho2O3:Al 1:1 (w/w) target material.

2.3. Distribution Coefficient Determination

The distribution coefficients (KD) at different HCl and HNO3 concentrations were measured to design the separation procedure for Er/Ho with LN2 resin. The KD values were measured by the batch method. Ten mL of solutions of different concentrations of HCl and HNO3 (0.05, 0.08, 0.1, 0.3, 0.5, 1.0, and 2 M) containing Er or Ho (1–2 mg) were mixed with 0.1 g LN2 resin. The mixtures were shaken overnight, and the solution was separated from the resin. The resin was washed with 5 mL of the corresponding HCl or HNO3 concentration and combined with the solution. The amount of Er or Ho in the solution was measured with ICP-OES. The resin was then washed with 15 mL 2 M HNO3, and the amount of Er or Ho on the resin was measured by analyzing these fractions. The KD values were calculated using Equation (3).
K D = m w a s h   o f   r e s i n m m o b i l e   p h a s e V w
mwash of resin and mmobile phase are the mass of Er or Ho in the 2 M HNO3 wash fraction of the resin and in the mobile phase at equilibrium, which is the initial 10 mL of solution and the 5 mL rinse solution with the corresponding HCl or HNO3 concentration. w is the weight of dry resin (g), and V is the volume of the initial 10 mL solution (mL).
The separation factor (α) was calculated from the KD values with Equation (4).
α b a t c h , E r , H o = K D , E r K D , H o

2.4. Full-Scale Separation Procedure

A 180 mg Ho2O3/Al (1/1 w/w) target had a suitable thickness for the 165Er production. The target was dissolved in 6 mL of 4 M HCl at 60 °C. The pH of the solution was adjusted to 2 with 2 M NaOH (around 6 mL). Alternatively, the dissolved target material was evaporated to dryness at 130 °C under argon flow and redissolved in 3–5 mL 0.01 M HNO3. The solution was loaded on a 4 g LN2 column that was previously washed with 60 mL 4 M HNO3 and conditioned with 120 mL 0.01 M HNO3. The column was washed with 10 mL 0.01 M HNO3, 40 mL 0.3 M HNO3, 60 mL 0.4 M HNO3, and 30 mL 0.5 M HNO3. 165Er was eluted in 20–30 mL 4 M HNO3. The column with LN2 resin could be regenerated with 60 mL 30% HCl, conditioned with 120 mL 0.01 M HNO3, and reused. Before storing the column for a longer time, it was washed with 120 mL of water. The eluate containing 165Er was evaporated to dryness and redissolved in 3–5 mL 0.01 M HNO3. Alternatively, the eluate was loaded on a column containing 1.2 g branched DGA (b-DGA) resin previously washed with 0.01 M HNO3 and conditioned with 4 M HNO3. The column was washed with 30 mL 0.5 M HNO3, and 165Er and traces of Ho were eluted in 20 mL 0.01 M HNO3. This solution was then loaded on a second 4 g LN2 column, which was washed with 4 M HNO3 and conditioned with 0.01 M HNO3. The column was then washed with 10 mL 0.01 M HNO3, 20 mL 0.6 M HNO3, 50–60 mL 0.7 M HNO3, and 5–10 mL 0.8 M HNO3. 165Er was eluted in 10–20 mL 4 M HNO3. A column with 0.1 g of TK221 resin has previously been used to concentrate and change the acid concentration of 165Er solutions [19]. The eluate from the second LN2 column was loaded directly on the TK221 column that had previously been washed with 10 mL 0.05 M HCl and conditioned with 10 mL 4 M HNO3. The column was washed with 10 mL 0.1 M HNO3. The 165Er was eluted in six 0.2 mL fractions with 0.05 M HCl.
The amount of Ho and Al in the different fractions was analyzed by ICP-OES. The separation factor for the dynamic separations using columns was calculated by Equation (5), where mHo,before and mHo,after are the mass of Ho before and after the separation, and A165Er,before and A165Er,after are the activity of 165Er before and after the separation.
α c o l u m n , E r , H o = m H o , b e f o r e / m H o , a f t e r A 165 E r , b e f o r e / A 165 E r , a f t e r

2.5. Radiochemical Purity, Chemical Purity, and Effective Molar Activity Determination

The samples were analyzed by X-ray spectrometry by spotting 10–50 µL of the samples on a piece of paper in a zip-lock plastic bag or by gamma spectrometry. The resolution of the two spectrometers was not sufficient to distinguish between all the emitted X-rays. For the X-ray spectrometry, 165Er was quantified from the 46.7, 47.5, and 55.3 keV lines, and the 53.6 and 53.9 keV lines were combined into one peak at 53.9 keV. For gamma spectrometry, the lines 46.7 and 47.5 keV were combined into one peak at 47.6 keV, and the 53.6 and 53.9 keV lines were also combined and found at 53.9 keV. The dose calibrator was mainly used to give a preliminary estimation of the activity. A calibration factor from a 165Er sample measured with the X-ray detector and the dose calibrator was applied. The calibration factor was 216 for samples in 10 mL glass vials. To determine the amount of stable metal impurities and the apparent molar activity, the samples were analyzed by ICP-OES. The samples were diluted in 1% HNO3 and analyzed against ICP-OES standards containing Er, Ho, Ag, Al, Ba, Ca, Cd, Co, Cr, Cu, Fe, Mg, Mn, Na, Ni, Pb, and Zn. The effective molar activity was measured for three different chelators: DOTA, DTPA, and CHX-A″-DTPA. Samples from the final formulation (10 µL, 14.9 MBq decay corrected to end of bombardment (EOB)) were combined with 230 µL 0.1 M ammonium acetate (pH 5–6) and increasing amounts of chelators (0.1 mM solutions) in 0.1 M ammonium acetate buffer (0.1, 0.2, 0.3, 0.4, 0.5, 0.7, and 1 nmol chelator). The samples containing DOTA were heated to 90 °C for 30 min, while the samples containing DTPA and CHX-A″-DTPA were left at room temperature for 30 min, and the reaction mixtures were spotted on normal phase TLC plates. A 50:50 methanol–water mixture of solvents containing 5% w/v ammonium acetate was used as the mobile phase. The Rf value was 0.4 for the 165Er-DOTA complex, 0.6 for the 165Er-DTPA complex, 0.7–0.8 for the 165Er-CHX-A″-DTPA complex, and 0 for non-chelated 165Er. The amount of metals in the samples was calculated by dividing the amount of added chelator by the ratio of the formed complex. The activity of the sample was divided by the amount of metals in the sample to determine the effective molar activity. Only samples showing 15–85% of complex formed were used for the calculation, as linearity was assumed in this region, and the average of these results was used for the effective molar activity calculation.

2.6. Serum Stability of 165Er Complexes

The stability of complexes prepared by mixing 150 µL of the final formulation (215.6 MBq 165Er decay corrected to EOB) and 15–50 µL of each ligand (DOTA, DTPA, and CHX-A′′-DTPA) solution (1.0 mM in acetate buffer 0.1 M, 15–50 nmol) and 100–150 µL 0.1 M ammonium acetate was evaluated. Full complexation was not seen with one of the samples containing CHX-A″-DTPA, so an additional 15 µL of CHX-A″-DTPA solution was added (30 nmol CHX-A″-DTPA in total), and the sample was heated to 90 °C for 30 min. After confirmation that full complexation was achieved by TLC analysis, 60–80 µL samples were mixed with mouse serum 420–540 µL and incubated for 27–28 h at 37 °C. The mixtures were analyzed by TLC after 0, 1, 3–4, 20–22, and 27–28 h using the same conditions as described in the previous section.

3. Results

3.1. Production of 165Er from Ho2O3:Al Target

Different amounts of Al powder were added to Ho2O3 to find the optimal target composition and irradiation conditions (Table 1). The Al powder was needed to prevent thermal damage to the target material otherwise observed even at a 10 µA beam current. Targets without Al and with a Ho2O3:Al ratio of 7:3 (w/w) became powdery (Figure 1), and a Ho2O3:Al ratio of 1:1 (w/w) was found to be the optimal ratio since larger amounts of Al decreased the production yield. Targets with a 1:1 ratio were stable up to 45 µA. When a beam current of 50 µA was applied for 15 min, the target material started to be discolored and damaged (Figure 2). The Nb foil was also more affected by the irradiation at 50 µA than at 45 µA, but was still intact (Appendix A). For irradiations of more than 15 min, a beam current of 25 µA was used, but the test of the maximal beam tolerance suggested that currents up to 40 µA would be acceptable for longer irradiations.
The 165Er production resulted in the coproduction of several short-lived radionuclidic impurities. 164g,mHo (T½: 28.8 min (ground state) and T½: 36.6 min (metastable state)) were produced from the 165Ho(p,pn)164Ho nuclear reaction and 166Ho from neutron activation. These Ho isotopes were produced in small amounts and followed the natHo in the separation procedure and were not found in the final product. 107Cd (T½: 6.5 h) was detected after the irradiation and was expected to be produced due to the use of Ag target backings. 56Co (T½: 77.2 d), 69Ge (T½: 38.9 h), and 66,67Ga (T½: 9.6 h and T½: 3.3 d) were expected to be produced from impurities in the target material by the (p,n) nuclear reaction from Fe, Ga, and Zn, respectively [6]. The radionuclidic impurities were also separated from 165Er with the purification procedure and did not affect the final radionuclidic purity.

3.2. Simulated Thermal Performance of the Target

The application of a cyclotron target consisting of a mixture of pressed powder made it challenging to predict the target stability and beam tolerance. For the calculation, the thermal conductivity was needed to calculate the heat dissipation and, therefore, had to be estimated for the Ho2O3:Al mixture. From the known thermal conductivity of Al and the estimated value for Ho2O3, we chose 30 W/m·K as our initial estimation for the 1:1 (w/w) mixture. From this calculation, the 180 mg target would reach a temperature of 645 °C by irradiation with a beam current of 52 µA, which could result in damage to the target, since the temperature would be at the limit of the melting point of Al (660 °C). The temperature of the Nb degrader at this beam current was calculated to be 1127 °C, which is below the melting point of Nb (2477 °C), indicating that the Ho2O3:Al 1:1 (w/w) target material was the limiting factor according to the calculations. Damage to the target was observed at a 50 µA beam current (Figure 2b), while the Nb foil was still intact (Appendix A). This indicated that the calculated maximal beam current tolerance was close to the experimental value despite the thermal conductivity of the target material being an estimation and experimental variations, e.g., for the target mass, mixture ratio, and beam profile shape that can affect the target performance. The data from the experiment were additionally used to adjust the value for the thermal conductivity of the Ho2O3:Al 1:1 (w/w) mixture, and by using a value of 24 W/m·K, the calculation matched the observed beam current tolerance.

3.3. Theoretical Yield Calculations

The maximum cross section for the natHo(p,n)165Er reaction is at 10 MeV according to cross section studies by Tárkányi et al., Gracheva et al., and Červenák et al. [11,12,13]. It was chosen to degrade the incoming proton beam to 15 MeV using a 0.1 mm Nb foil. According to SRIM-2013 software calculations [27], the target thickness of a Ho2O3:Al 1:1 (w/w) target needs to be 276 g/cm2, corresponding to 175 mg with a 9 mm diameter target to cover the energy range from 15 MeV to 8 MeV. The calculation is associated with some uncertainty since the density of the Ho2O3:Al mixture is not known. The yield was calculated to be 19.5 MBq/µAh using the cross-section measurements by Tárkányi et al. [11] compared to 12.3 MBq/µAh for the experimental yield for the 180 mg target, which corresponds to 63% of the calculated value. The added Al decreases the production yield since it also dilutes the amount of Ho present in the target material, and the Al contributes to the stopping of the proton beam. It was calculated how much higher beam current the target should be able to tolerate to compensate for the added Al powder. A Ho2O3 target that covers the same energy range as the 175 mg Ho2O3:Al 1:1 w/w target would have a thickness of 348 mg/cm2 and a theoretical production yield of 49.2 MBq/µAh, which suggests that the target containing Al should withstand a proton beam current 2.5 times higher than the target without Al. Our initial experiments showed that the Ho2O3 target already showed signs of damage at 10 µA, while the target containing Al in a 1:1 ratio could withstand a beam current of 45 µA. This shows that the amount of produced 165Er is improved by adding Al powder to the Ho2O3 target material.

3.4. 165Er Purification Procedure

3.4.1. KD Values and Separation Factor for Batch Separations

From the KD studies, it was found that Er has a higher affinity for the LN2 resin compared to Ho at HCl and HNO3 concentrations below 1 M (Figure 3). The binding affinity of Er was relatively low at HCl and HNO3 concentrations above 1 M, which suggested that it would be possible to elute the Er effectively after eluting Ho at a lower acid concentration. In general, a higher separation factor was seen with HNO3 compared to HCl (Figure 4). For the dynamic separations, both HCl and HNO3 were tested.

3.4.2. Full-Scale Procedure

The separation of Er/Ho was tested in small-scale on LN2 columns to estimate the resin capacity, eluent concentrations, and flow rate, and to compare HCl and HNO3 as an eluent. The details for these experiments can be found in Appendix B. From the initial experiments, a purification procedure for a full-scale 165Er production was developed using three columns: two with LN2 resin and one column containing TK221 resin. An overview of the purification method can be seen in Figure 5.
The target could be dissolved in 4 M HCl at 60 °C within an hour and was loaded on the column after pH adjustment. HNO3 was chosen as an eluent due to the higher separation factor, and it was found that 4 g of LN2 resin was suitable for the purification of 165Er from the 180 mg Ho2O3:Al 1:1 (w/w) target. From the capacity study (Appendix B), it was expected that 2 g of LN2 resin would be sufficient, but due to the relatively large amount of Al, 4 g of resin was chosen and found to give an acceptable 165Er/Ho separation. The first column was mainly separating the bulk Ho and Al from 165Er. It was attempted to maintain a high 165Er recovery from the first column since a higher separation factor could be obtained after removing a large amount of Ho and the Al. The highest separation factor from the KD study was at 0.08–0.1 M HNO3, but for the dynamic separation procedures using columns, the elution of Ho at this concentration would require large volumes of eluents due to the high KD value. Increasing the concentration of HNO3 from 0.3 to 0.5 M made it possible to elute the majority of Ho with limited co-elution of 165Er. The 165Er could subsequently be eluted in 20–30 mL 4 M HNO3 (Figure 6).
The separation of Er from Ho was not sufficient, with one LN2 column containing 4 g of resin. And it was decided not to increase the amount of LN2 resin for the first column, since it was expected to be more efficient to use multiple LN2 columns. To load the eluate from the first LN2 column to a second one, the acid concentration needed to be reduced from 4 M to around 0.01 M. The eluate from the first LN2 column was evaporated to dryness and redissolved in 0.01 M HNO3 and loaded on a second LN2 column. To avoid an evaporation step in the purification procedure, a column with DGA resin can be used to change the acid concentration. The DGA column could also be used to remove remaining Al, since Al had a very low adsorption to DGA resin over a broad range of HNO3 concentrations. Er and Ho bind to DGA resin over a broad range of HNO3 concentration, making it possible to load the eluate from the LN2 column and wash the DGA column with 0.5 M HNO3 without eluting Er and Ho. The elution with 0.01 M HNO3 was quantitative, and the eluate could be loaded directly on the second LN2 column. It was possible to reuse the same 4 g LN2 column, which reduced the amount of resin needed. Ho was eluted in 0.6–0.8 M HNO3, and 165Er started eluting with 0.8 M HNO3, which meant that a balance between a high recovery and a high purity needed to be found. 165Er was eluted in 10–20 mL of 4 M HNO3 (Figure 7).
The large volume and high HNO3 concentration of the eluate fractions from the second LN2 column were not suitable for 165Er radiolabeling studies, so the 4 M HNO3 eluate fractions were passed through a small column containing TK221 resin. 165Er had a high affinity for the resin in 0.5–4 M HNO3 and could be eluted in a small volume of 0.05 M HCl (400–600 µL, 89.9 ± 9.0% 165Er recovery). This step also reduced the amount of contaminants, such as Fe and Ca. The main chemical impurities according to ICP-OES were Ho, Ca, and Fe, and in one batch, Pb was observed as an additional contaminant. The purification procedure from EOB to the end of purification (EOP) took around 8 h, which is close to one half-life of 165Er. An overview of the metal impurities in the final 165Er product, together with the radionuclidic purity, separation factor, and the recovery, can be found in Table 2. The X-ray spectrum of 165Er after purification can be seen in Figure 8, and the gamma spectrum in Appendix C. No radionuclidic impurities were detected in the final product. In the X-ray spectrum, ghost peaks between 30–40 keV were detected, arising from escape of the Ge K-shell X-ray emitted following photoelectric interactions of the 47 and 48 keV photons.

3.5. Effective Molar Activity Determination

The effective molar activity of the final 165Er was calculated from titration with the three chelators, DTPA, CHX-A″-DTPA, and DOTA. The percentage of formed complex can be seen in Figure 9. The effective molar activity was decay corrected to the time of EOB and was 17.8 ± 4.6 MBq/nmol for DTPA, 15.9 ± 5.3 MBq/nmol for CHX-A″-DTPA, and 19.4 ± 2.7 MBq/nmol for DOTA. The apparent molar activity of the same 165Er batch calculated from ICP-OES was 24.9 MBq/nmol, and the detected metal impurities were Ho, Er, Fe, Ca, and Pb. Ca was not expected to compete with 165Er for the binding to the three chosen chelators, and the apparent molar activity, excluding Ca, was 36.3 MBq/nmol. The effective molar activity was lower than the apparent molar activity determined from ICP-OES, which could suggest that metal impurities might be present in the sample that were not included in the ICP-OES analysis.

3.6. Serum Stability of 165Er-Complexes

The [165Er]Er-DTPA, [165Er]Er-CHX-A″-DTPA, and [165Er]Er-DOTA complex formation was confirmed by radio-TLC, and the complexes were mixed with mouse serum and incubated at 37 °C for up to 28 h. All three complexes were stable under the test conditions, and no free 165Er or other decomplexation was observed.

4. Discussion

The use of pressed Ho2O3:Al cyclotron targets was suitable for 165Er production. The addition of Al powder to the Ho2O3 target material ensured high robustness and reliability of the target, even though the production yield was compromised. The higher beam current tolerance compensated for this effect, since the current could be increased 4–4.5 times. Due to the limited data available for pressed mixed powder targets, we performed calculations using the numerical solution of the heat transport equations for the target geometry and an estimated thermal conductivity to predict the maximal beam current tolerance of the Ho2O3:Al 1:1 (w/w) target. The calculations gave a beneficial indication and could also be helpful for the further development of pressed powder targets. The quantification of 165Er came with some difficulties due to the absence of γ-ray emission. Small samples spotted on pieces of paper in plastic bags were used for the quantification to simulate point sources and limit absorption of the low-energy X-rays. The resolution on the detectors was not sufficient to resolve all the emitted X-rays, but an acceptable agreement between the different X-ray lines was achieved by combining some of the lines.
The rather low cross-section of the reaction natHo(p,n)165Er poses challenges for the scalability of 165Er production on a medical cyclotron. However, the production of radionuclides by irradiation on medical cyclotrons has two advantages: First, competing nuclear reactions leading to the production of multiple radionuclides of the same element can usually be avoided. Second, in comparison to facilities running high-energy beams, there is a larger number of medical cyclotrons available. They offer a reliable and regular supply of the desired radionuclide, as well as shorter transportation times to the receiving medical facilities, which is especially important for radionuclides with half-lives shorter than a day. The half-life of 165Er is relatively short for application in therapy, making local processing and application preferable to obtain the highest possible molar activity. It is also important to apply radiopharmaceuticals with pharmacokinetics that match the half-life of 165Er to obtain high uptake and efficient clearance [5]. The relatively short half-life of 165Er and the similar chemical properties of Er and Ho are challenges for the separation process, but the 165Er/Ho separation is possible with two LN2 resin columns, one b-DGA resin column, or an evaporation step and one small column containing TK221 resin. In cases where the final chemical purity of the 165Er can be compromised, a shorter purification procedure using, e.g., only one LN2 column could be considered. Higher purity can potentially be obtained by using additional LN2 resin columns, but large volumes (300–400 mL) of eluents are required due to the large amount of resin needed, and the acid concentration needs to be adjusted between the columns, which is time-consuming. We estimate to be limited to around 1 GBq of 165Er at EOP with the current procedure, which is expected to be sufficient for preclinical studies. Despite the challenging scalability and separation procedure, 165Er is highly relevant for studying the AE effect, since only X-rays are emitted together with the AEs. Furthermore, non-enriched target material can be used for production, and conventional chelators can easily be labeled with 165Er. The labeling of the three tested chelators, DOTA, DTPA, and CHX-A″-DTPA, with 165Er was efficient, with a high radiochemical purity and similar effective molar activity. The three 165Er complexes showed no degradation in mouse serum for up to 28 h, which enables the possibility of applying a large variety of radiotracers with one of the three chelators facilitating labeling both at room temperature and at elevated temperatures.

5. Conclusions

A procedure for 165Er production using pressed Ho2O3:Al cyclotron targets on a 16.5 MeV cyclotron was developed together with a 165Er/Ho separation method using LN2 and TK221 extraction resins. The cyclotron target shows higher stability towards the proton beam when Al powder is added, and a 180 mg Ho2O3:Al 1:1 (w/w) can withstand beam currents up to 45 µA, which could also be simulated by temperature and heat dissipation calculations. A 165Er production yield of 12.3 ± 1.9 MBq/µAh was reached. To obtain 165Er in a purity suitable for further radiolabeling and application, two relatively large LN2 resin columns were used for the separation, followed by a small TK221 resin column to concentrate the final 165Er product. The final 165Er reached an apparent molar activity decay corrected to EOB of 24.9 MBq/nmol according to ICP-OES and was suitable for the labeling of DOTA, DTPA, and CHX-A″-DTPA chelators, which formed 165Er complexes with high stability in mouse serum. The target development and separation procedure are part of increasing the availability of 165Er for potential further studies of AE effect and therapeutic efficacy.

Author Contributions

Conceptualization, K.S.P., C.D., C.N. and M.J.; methodology, K.S.P., T.B., G.T., C.N. and M.J.; formal analysis, K.S.P., C.D., T.B. and G.T.; investigation, K.S.P., C.D., T.B. and G.T.; writing—original draft preparation, K.S.P. and C.D.; writing—review and editing, C.N. and M.J.; visualization, K.S.P. and C.D. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by the European Union’s Horizon 2020 research and innovation programme under grant agreement No 101008571 (PRISMAP—The European medical radionuclides programme).

Data Availability Statement

The raw data supporting the conclusions of this article will be made available by the authors upon request.

Conflicts of Interest

The authors declare no conflicts of interest.

Abbreviations

The following abbreviations are used in this manuscript:
αSeparation factor
AEAuger electron
CHX-A″-DTPA[(R)-2-Amino-3-(4-nitrophenyl)propyl]-trans-(S,S)-cyclohexane-1,2-diamine-pentaacetic acid
DOTA1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid
DTPADiethylene triaminepentaacetic acid
EOBEnd of bombardment
EOPEnd of purification
HPGeHigh-purity germanium
ICP-OESInductively coupled plasma optical emission spectroscopy
KDDistribution coefficient
LODLimit of detection
SPECTSingle-photon emission computed tomography
TLCThin-layer chromatography

Appendix A

Figure A1. 0.1 mm Nb foil after irradiation for 15 min at (a) 45 µA and (b) 50 µA.
Figure A1. 0.1 mm Nb foil after irradiation for 15 min at (a) 45 µA and (b) 50 µA.
Instruments 10 00014 g0a1

Appendix B

Appendix B.1. Methods for the Initial Separation Tests

For the initial tests, the Er/Ho separation was followed using 165Er and 166Ho and analyzing the amount of Ho and Al from the target material with ICP-OES. Loaded on a 3 mL column with 600 mg of LN2 resin were 23–33 mg of Ho, which were conditioned with 0.01 M HCl. The column was washed with 10 mL of 0.01 M HCl, 30 mL of 0.2 M HCl, and 40 mL of 0.3 M HCl and eluted in 10 mL of 2 M HCl. The effect of Al was tested by loading 21–24 mg of Ho together with 0–70 mg of Al on a 3 mL column containing 1.2 g of LN2 resin. The column was washed with 10 mL of 0.01 M HCl, 20–30 mL of 0.3 M HCl, and 10–40 mL of 0.4 M HCl, and 165Er was eluted in 10 mL of 2–5 M HCl. A flow rate of 1 mL/min was used for the initial experiments, but it was also tested to increase the flow rate to 2 mL/min with a 1.3 g LN2 column with 23 mg of Ho loaded on the column. The Er/Ho separation on LN2 resin was also tested with HNO3 as an eluent, where 20 mg of Ho and 16 mg of Al were loaded on a 1.2 g LN2 column in 0.01 M of HNO3, and the column was washed with 30 mL of 0.2 M HNO3, 30 mL of 0.3 M HNO3, and 40 mL of 0.4 M HNO3. 165Er was eluted in 10 mL of 4 M HNO3. The same experiment was repeated, where only 40 mL of 0.4 M HNO3 was used for washing the column and eluting Ho.

Appendix B.2. Results for the Initial Separation Tests

The capacity of the resin was tested by loading 33 and 23 mg of Ho on 600 mg of LN2 resin, respectively. In the separation with 33 mg of Ho, around a fourth of the 165Er was co-eluted with Ho in the 0.2 M HCl wash fraction, while only 6% of 165Er was co-eluted with Ho in the separation with 23 mg of Ho. Around 26 mg of LN2 resin per mg of Ho seemed necessary to ensure that the capacity of the resin was not exceeded.
During the design of the cyclotron target for the 165Er production, it was seen that the addition of Al powder to the Ho2O3 target material made it possible to increase the stability of the target at higher beam current. The effect of Al in the separation procedure was tested by comparing the separation performance in an experiment without Al, with 8 mg of Al, 15 mg of Al, and 69 mg of Al. It was seen that the recovery of 165Er was affected by the addition of Al. Acceptable recovery was achieved with 0–15 mg of Al (82–92% 165Er recovery), but when 69 mg of Al was added, only half of the 165Er was recovered, and the eluate fraction also contained around 15% Ho.
The flow rate was increased from 1 mL/min to 2 mL/min without affecting the separation performance. In a test with 21–23 mg of Ho and 8 mg of Al loaded on 1.3 g of LN2 resin, a flow rate of 1 mL/min led to a loss of 13% 165Er in the wash fractions, and a flow rate of 2 mL/min led to 15% 165Er loss. A flow rate of 2 mL/min was used for further separation procedures.
By comparing the Er/Ho separation on LN2 resin using HCl and HNO3 as eluents, a lower co-elution of 165Er was seen in the Ho fractions when using HNO3, which also matches the higher separation factor in HNO3 found by the KD study.

Appendix C

Figure A2. The gamma spectrum of the final 165Er product from 0–2000 keV.
Figure A2. The gamma spectrum of the final 165Er product from 0–2000 keV.
Instruments 10 00014 g0a2

References

  1. Idrissou, M.B.; Pichard, A.; Tee, B.; Kibedi, T.; Poty, S.; Pouget, J.P. Targeted Radionuclide Therapy Using Auger Electron Emitters: The Quest for the Right Vector and the Right Radionuclide. Pharmaceutics 2021, 13, 980. [Google Scholar] [CrossRef] [PubMed]
  2. Ku, A.; Facca, V.J.; Cai, Z.; Reilly, R.M. Auger Electrons for Cancer Therapy—A Review. EJNMMI Radiopharm. Chem. 2019, 4, 27. [Google Scholar] [CrossRef] [PubMed]
  3. Müller, C.; Reber, J.; Haller, S.; Dorrer, H.; Bernhardt, P.; Zhernosekov, K.; Türler, A.; Schibli, R. Direct in Vitro and in Vivo Comparison of 161Tb and 177Lu Using a Tumour-Targeting Folate Conjugate. Eur. J. Nucl. Med. Mol. Imaging 2014, 41, 476–485. [Google Scholar] [CrossRef] [PubMed]
  4. Müller, C.; Umbricht, C.A.; Gracheva, N.; Tschan, V.J.; Pellegrini, G.; Bernhardt, P.; Zeevaart, J.R.; Köster, U.; Schibli, R.; van der Meulen, N.P. Terbium-161 for PSMA-Targeted Radionuclide Therapy of Prostate Cancer. Eur. J. Nucl. Med. Mol. Imaging 2019, 46, 1919–1930. [Google Scholar] [CrossRef]
  5. Bolcaen, J.; Gizawy, M.A.; Terry, S.Y.A.; Paulo, A.; Cornelissen, B.; Korde, A.; Engle, J.; Radchenko, V.; Howell, R.W. Marshalling the Potential of Auger Electron Radiopharmaceutical Therapy. J. Nucl. Med. 2023, 64, 1344–1351. [Google Scholar] [CrossRef]
  6. National Nuclear Data Center (NNDC). NuDat 3.0. Available online: https://www.nndc.bnl.gov/nudat3/ (accessed on 23 September 2025).
  7. ICRP. Nuclear Decay Data for Dosimetric Calculations; ICRP Publication 107; ICRP: Ottawa, ON, Canada, 2008; Volume 38. [Google Scholar] [CrossRef]
  8. Saghez, B.S.; Rodríguez-Rodríguez, C.; Esquinas, P.L.; Merkens, H.; Bénard, F.; Radchenko, V.; Yang, H. First Preclinical SPECT/CT Imaging and Biodistribution of [165Er]ErCl3 and [165Er]Er-PSMA-617. EJNMMI Radiopharm. Chem. 2024, 9, 90. [Google Scholar] [CrossRef]
  9. Malikidogo, K.P.; Da Silva, I.; Morfin, J.F.; Lacerda, S.; Barantin, L.; Sauvage, T.; Sobilo, J.; Lerondel, S.; Tóth, É.; Bonnet, C.S. A Cocktail of 165Er(III) and Gd(III) Complexes for Quantitative Detection of Zinc Using SPECT and MRI. Chem. Commun. 2018, 54, 7597–7600. [Google Scholar] [CrossRef]
  10. Beyer, G.J.; Zeisler, S.K.; Becker, D.W. The Auger-Electron Emitter 165Er: Excitation Function of the 165Ho(p, n)165Er Process. Radiochim. Acta 2004, 92, 219–222. [Google Scholar] [CrossRef]
  11. Tárkányi, F.; Hermanne, A.; Takács, S.; Ditrói, F.; Király, B.; Kovalev, S.F.; Ignatyuk, A.V. Experimental Study of the 165Ho(p,n) Nuclear Reaction for Production of the Therapeutic Radioisotope 165Er. Nucl. Instrum. Methods Phys. Res. Sect. B Beam Interact. Mater. At. 2008, 266, 3346–3352. [Google Scholar] [CrossRef]
  12. Gracheva, N.; Carzaniga, T.S.; Schibli, R.; Braccini, S.; van der Meulen, N.P. 165Er: A New Candidate for Auger Electron Therapy and Its Possible Cyclotron Production from Natural Holmium Targets. Appl. Radiat. Isot. 2020, 159, 109079. [Google Scholar] [CrossRef]
  13. Červenák, J.; Fialová, K.O.; Ondrák, L.; Lebeda, O. New Cross Sections for 165Ho(p,x) Reactions Focused on Production of a Perspective Auger Electron Emitter 165Er. Appl. Radiat. Isot. 2025, 225, 112088. [Google Scholar] [CrossRef] [PubMed]
  14. Tárkányi, F.; Takács, S.; Hermanne, A.; Ditrói, F.; Király, B.; Baba, M.; Ohtsuki, T.; Kovalev, S.F.; Ignatyuk, A.V. Investigation of Production of the Therapeutic Radioisotope 165Er by Proton Induced Reactions on Erbium in Comparison with Other Production Routes. Appl. Radiat. Isot. 2009, 67, 243–247. [Google Scholar] [CrossRef] [PubMed]
  15. Vaudon, J.; Frealle, L.; Audiger, G.; Dutillly, E.; Gervais, M.; Sursin, E.; Ruggeri, C.; Duval, F.; Bouchetou, M.L.; Bombard, A.; et al. First Steps at the Cyclotron of Orléans in the Radiochemistry of Radiometals: 52Mn and 165Er. Instruments 2018, 2, 15. [Google Scholar] [CrossRef]
  16. Dellepiane, G.; Casolaro, P.; Favaretto, C.; Gottstein, A.; Grundler, P.V.; Mateu, I.; Renaldin, E.; Scampoli, P.; Talip, Z.; van der Meulen, N.P.; et al. Cross-Section Measurement of Thulium Radioisotopes with an 18 MeV Medical PET Cyclotron for an Optimized 165Er Production. Appl. Radiat. Isot. 2023, 200, 110954. [Google Scholar] [CrossRef]
  17. Tárkányi, F.; Hermanne, A.; Takács, S.; Ditrói, F.; Király, B.; Kovalev, S.F.; Ignatyuk, A.V. Experimental Study of the 165Ho(d, 2n) and 165Ho(d, p) Nuclear Reactions up to 20 MeV for Production of the Therapeutic Radioisotopes 165Er and 166gHo. Nucl. Instrum. Methods Phys. Res. Sect. B Beam Interact. Mater. At. 2008, 266, 3529–3534. [Google Scholar] [CrossRef]
  18. Da Silva, I.; Johnson, T.R.; Mixdorf, J.C.; Aluicio-Sarduy, E.; Barnhart, T.E.; Jerome Nickles, R.; Engle, J.W.; Ellison, P.A. A High Separation Factor for 165Er from Ho for Targeted Radionuclide Therapy. Molecules 2021, 26, 7513. [Google Scholar] [CrossRef]
  19. Saghez, B.S.; Yang, H.; Radchenko, V. High Separation Factor, High Molar Activity, and Inexpensive Purification Method for the Production of Pure 165Er. Inorg. Chem. 2024, 63, 5330–5340. [Google Scholar] [CrossRef]
  20. Pedersen, K.S.; Deville, C.; Søndergaard, U.; Jensen, M.; Jensen, A.I. Improved Procedures for Production and Purification of 135La from Enriched [135Ba]BaCO3 on a 16.5 MeV Cyclotron. Appl. Radiat. Isot. 2023, 192, 110612. [Google Scholar] [CrossRef]
  21. Byegård, J.; Skarnemark, G.; Skålberg, M. The Stability of Some Metal EDTA, DTPA and DOTA Complexes: Application as Tracers in Groundwater Studies. J. Radioanal. Nucl. Chem. 1999, 241, 281–290. [Google Scholar] [CrossRef]
  22. Viola-Villegas, N.; Doyle, R.P. The Coordination Chemistry of 1,4,7,10-Tetraazacyclododecane-N,N′,N″,N‴-Tetra Acetic Acid (H4DOTA): Structural Overview and Analyses on Structure-Stability Relationships. Coord. Chem. Rev. 2009, 253, 1906–1925. [Google Scholar] [CrossRef]
  23. Pandey, U.; Gamre, N.; Lohar, S.P.; Dash, A. A Systematic Study on the Utility of CHX-A″-DTPA-NCS and NOTA-NCS as Bifunctional Chelators for 177Lu Radiopharmaceuticals. Appl. Radiat. Isot. 2017, 127, 1–6. [Google Scholar] [CrossRef]
  24. Avila-Rodriguez, M.A.; Sader, J.A.; McQuarrie, S.A. 3D Modeling and Simulation of the Thermal Performance of Solid Cyclotron Targets. In Proceedings of the COMSOL Conference, Boston, MA, USA, 4–6 October 2007. [Google Scholar]
  25. Thisgaard, H.; Jensen, M.; Elema, D.R. Medium to Large Scale Radioisotope Production for Targeted Radiotherapy Using a Small PET Cyclotron. Appl. Radiat. Isot. 2011, 69, 1–7. [Google Scholar] [CrossRef]
  26. Zhang, A.; Li, Y. Thermal Conductivity of Aluminum Alloys—A Review. Materials 2023, 16, 2972. [Google Scholar] [CrossRef]
  27. Ziegler, J.F.; Ziegler, M.D.; Biersack, J.P. SRIM The Stopping and Range of Ions in Matter. Nucl. Instrum. Methods Phys. Res. Sect. B Beam Interact. Mater. At. 2010, 268, 1818–1823. [Google Scholar] [CrossRef]
Figure 1. Pressed Ho2O3 targets containing various amounts of Al powder after 10 min irradiation at 10 µA. (a) Ho2O3 target without Al powder, (b) Ho2O3:Al 7:3 (w/w), (c) Ho2O3:Al 1:1 (w/w), and (d) Ho2O3:Al 1:2 (w/w).
Figure 1. Pressed Ho2O3 targets containing various amounts of Al powder after 10 min irradiation at 10 µA. (a) Ho2O3 target without Al powder, (b) Ho2O3:Al 7:3 (w/w), (c) Ho2O3:Al 1:1 (w/w), and (d) Ho2O3:Al 1:2 (w/w).
Instruments 10 00014 g001
Figure 2. The pressed 180 mg Ho2O3:Al 1:1 (w/w) target after 15 min irradiated (a) at 45 µA and (b) at 50 µA.
Figure 2. The pressed 180 mg Ho2O3:Al 1:1 (w/w) target after 15 min irradiated (a) at 45 µA and (b) at 50 µA.
Instruments 10 00014 g002
Figure 3. Graph showing the KD values for Er and Ho on LN2 resin in 0.05 M to 2 M HNO3 and HCl.
Figure 3. Graph showing the KD values for Er and Ho on LN2 resin in 0.05 M to 2 M HNO3 and HCl.
Instruments 10 00014 g003
Figure 4. The separation factor for Er/Ho on LN2 resin in 0.05 M to 2 M HNO3 and HCl from the batch method experiments.
Figure 4. The separation factor for Er/Ho on LN2 resin in 0.05 M to 2 M HNO3 and HCl from the batch method experiments.
Instruments 10 00014 g004
Figure 5. Overview of the separation procedure for a full batch of 165Er produced from a 180 mg Ho2O3:Al 1:1 (w/w) target.
Figure 5. Overview of the separation procedure for a full batch of 165Er produced from a 180 mg Ho2O3:Al 1:1 (w/w) target.
Instruments 10 00014 g005
Figure 6. Elution profile for the first 4 g LN2 column. Al was eluted in the load and 0.01 M HNO3 wash fraction, Ho was eluted in 0.3–0.5 M HNO3, and 165Er was eluted in 4 M HNO3.
Figure 6. Elution profile for the first 4 g LN2 column. Al was eluted in the load and 0.01 M HNO3 wash fraction, Ho was eluted in 0.3–0.5 M HNO3, and 165Er was eluted in 4 M HNO3.
Instruments 10 00014 g006
Figure 7. Elution profile of the second 4 g LN2 column. Ho was eluted in 0.6–0.8 M HNO3, and 165Er was eluted in 4 M HNO3.
Figure 7. Elution profile of the second 4 g LN2 column. Ho was eluted in 0.6–0.8 M HNO3, and 165Er was eluted in 4 M HNO3.
Instruments 10 00014 g007
Figure 8. The X-ray spectrum of 165Er after the purification procedure from 0–120 keV.
Figure 8. The X-ray spectrum of 165Er after the purification procedure from 0–120 keV.
Instruments 10 00014 g008
Figure 9. The percentage of formed [165Er]Er-DTPA (red squares), [165Er]Er-CHX-A″-DTPA (blue circles), and [165Er]Er-DOTA (green triangles) complexes at different amounts of chelator added to samples of the final 165Er product.
Figure 9. The percentage of formed [165Er]Er-DTPA (red squares), [165Er]Er-CHX-A″-DTPA (blue circles), and [165Er]Er-DOTA (green triangles) complexes at different amounts of chelator added to samples of the final 165Er product.
Instruments 10 00014 g009
Table 1. The target composition, irradiation conditions, and production yield for the tested targets. The targets were irradiated for 10–180 min with a 0.1 mm Nb foil, degrading the proton beam energy.
Table 1. The target composition, irradiation conditions, and production yield for the tested targets. The targets were irradiated for 10–180 min with a 0.1 mm Nb foil, degrading the proton beam energy.
Ho2O3 (mg)Al (mg)Current (µA)165Er Yield (MBq/µAh)Target in Figure 1
910104.4a
9138106.4b
909010–5012.3 ± 1.9c
67133158.4-
9018010–157.8 ± 0.6 d
Table 2. Overview of the radionuclidic purity, 165Er recovery, chemical impurities in the final 165Er product, and the separation factors. The separation factors were calculated for each individual purification run and then averaged. The values for Al and Zn were below the limit of detection (LOD).
Table 2. Overview of the radionuclidic purity, 165Er recovery, chemical impurities in the final 165Er product, and the separation factors. The separation factors were calculated for each individual purification run and then averaged. The values for Al and Zn were below the limit of detection (LOD).
Radionuclidic purity at EOP (%)>99.9%
Overall 165Er separation recovery (%)77.9 ± 21.2
Er (nmol)1.8 ± 0.1
Ho (nmol)10.5 ± 8.9
Al (nmol)<17 (LOD)
Zn (nmol)<0.1 (LOD)
Fe (nmol)1.3 ± 1.2
Ca (nmol)16.1 ± 8.8
Pb (nmol)21.2 ± 28.8
αcolumn,Er,Ho first LN2 column37.4 ± 25.5
αcolumn,Er,Ho second LN2 column1.9·103 ± 4.7·102
Overall αcolumn,Er,Ho4.9·104 ± 3.2·104
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Søborg Pedersen, K.; Deville, C.; Borre, T.; Torabi, G.; Naidoo, C.; Jensen, M. Production and Purification of 165Er from Pressed Ho2O3:Al Targets on a 16.5 MeV Cyclotron. Instruments 2026, 10, 14. https://doi.org/10.3390/instruments10010014

AMA Style

Søborg Pedersen K, Deville C, Borre T, Torabi G, Naidoo C, Jensen M. Production and Purification of 165Er from Pressed Ho2O3:Al Targets on a 16.5 MeV Cyclotron. Instruments. 2026; 10(1):14. https://doi.org/10.3390/instruments10010014

Chicago/Turabian Style

Søborg Pedersen, Kristina, Claire Deville, Trine Borre, Ghazal Torabi, Clive Naidoo, and Mikael Jensen. 2026. "Production and Purification of 165Er from Pressed Ho2O3:Al Targets on a 16.5 MeV Cyclotron" Instruments 10, no. 1: 14. https://doi.org/10.3390/instruments10010014

APA Style

Søborg Pedersen, K., Deville, C., Borre, T., Torabi, G., Naidoo, C., & Jensen, M. (2026). Production and Purification of 165Er from Pressed Ho2O3:Al Targets on a 16.5 MeV Cyclotron. Instruments, 10(1), 14. https://doi.org/10.3390/instruments10010014

Article Metrics

Back to TopTop